Clinical Trial Detail

NCT ID NCT01603004
Title Potential Imaging and Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

islet cell tumor

Therapies

Everolimus

Sunitinib

Age Groups: adult

No variant requirements are available.